Evidence map›Paper›PMID 42831148›Full record

ArticleOphthalmology science2026

Inflammatory Markers and Disease Progression in Moderate-Stage Retinitis Pigmentosa: Longitudinal Analysis from the Retinitis Pigmentosa Progression and Inflammatory Marker Registry Study.

Sakurako Shimokawa, Kaho Yamamoto, Takahiro Hisai, Masatoshi Fukushima, Kohta Fujiwara, Yoshito Koyanagi, Shoji Notomi, Keijiro Ishikawa, Shoko Tsukamoto, Akie Hirata and 12 more

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sakurako ShimokawaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kaho YamamotoDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takahiro HisaiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masatoshi FukushimaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kohta FujiwaraDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshito KoyanagiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shoji NotomiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Keijiro IshikawaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shoko TsukamotoDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akie HirataDepartment of Medical Informatics, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Atsushi TakadaMedical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Fuyuka MiyaharaMedical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Naoki NakashimaDepartment of Medical Informatics, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yuko KobayakawaCenter for Clinical and Translational Research, Kyushu University Hospital, Fukuoka, Japan.
Go MawatariDepartment of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Masataka IshizuDepartment of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Naoki ToyamaMiyata Eye Hospital, Miyazaki, Japan.
Tomoko KaidaMiyata Eye Hospital, Miyazaki, Japan.
Kazunori MiyataMiyata Eye Hospital, Miyazaki, Japan.
Yasuhiro IkedaDepartment of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Koh-Hei SonodaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yusuke MurakamiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate longitudinal changes in visual functional and structural measures and to evaluate whether inflammatory markers are associated with disease progression in patients with moderate-stage retinitis pigmentosa (RP). Design: Multicenter 24-month prospective cohort study (RP-PRIMARY [Retinitis Pigmentosa Progression and Inflammatory Marker Registry]); longitudinal analysis. Participants: Sixty-seven patients aged 20-70 years with typical moderate-stage RP; 66 patients completed 24-month follow-ups. Methods: ETDRS best-corrected visual acuity (BCVA), Humphrey Field Analyzer 10-2 perimetry, OCT, and fundus autofluorescence (AF) were assessed longitudinally. Aqueous flare and systemic inflammatory markers (interleukin 8 [IL-8], intermediate monocyte proportion, and high-sensitivity C-reactive protein [hs-CRP]) were measured annually. Longitudinal changes in functional and structural outcomes were evaluated using linear mixed-effects models. Associations between baseline inflammatory markers and disease progression were assessed using linear mixed-effects models, adjusted for age, sex, intraocular lens status, and baseline ellipsoid zone (EZ) vertical length. Main Outcome Measures: Annual rates of change in visual functional and structural measures and their associations with inflammatory markers. Results: Over the 24-month follow-up period, ETDRS BCVA, mean deviation, central retinal sensitivity, EZ length, central foveal thickness, and AF ring area all showed significant progression. Higher baseline aqueous flare was associated with faster decline in central 12-point mean retinal sensitivity and EZ vertical length. Higher baseline intermediate monocyte proportion and hs-CRP were associated with faster ETDRS BCVA decline. Conversely, higher aqueous flare and intermediate monocyte proportion were associated with slower AF ring constriction, while higher hs-CRP was associated with slower central foveal thinning. No significant longitudinal associations were observed for IL-8. Conclusions: Visual functional and structural measures demonstrated significant progression over 2 years in moderate-stage RP. Baseline aqueous flare, intermediate monocyte proportion, and hs-CRP were associated with disease progression, supporting their potential as exploratory biomarkers for identifying patients at risk of faster progression. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Aqueous flareDisease progressionProspective studyRetinitis pigmentosaVisual function

Identifiers

PMID42831148
PMCPMC13634498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.